On May 29, 2026, a senator from Montana called for an immediate review of safety measures at a National Institutes of Health facility that studies highly infectious diseases.
The senator's request highlights growing concerns regarding public safety and the transparency of the lab's operations.
As the investigation unfolds, the focus will likely remain on the protocols in place to manage potentially dangerous pathogens.